
Fernanda S. Correia‐Melo, Gustavo C. Leal, Michelle S. Carvalho, Ana Paula Jesus‐Nunes, Carolina Barbosa Ferreira, Flávia Vieira, Guilherme Magnavita, Lucas A.S. Vale, Rodrigo P. Mello, Carolina Nakahira, Felipe Coelho Argôlo, Tanise L Cardoso, CEZAR DANIEL SNAK DE SOUZA, Ana Teresa Caliman‐Fontes, Marcelo B. Ferreira, Lucas Araújo-de-Freitas, Marco Aurélio Tuena, Mariana V.F. Echegaray, Diogo Esmeraldo Cavalcanti, Ana Cecília Lucchese, Igor D. Bandeira, Manuela Telles, Cassio Santos‐Lima, Aline S. Sampaio, Samantha S. Silva, Roberta Ferrari Marback, José Alberto Del-Porto, José Neander Abreu, Luciana Maria Sarin, Camilla S. Paixão, Lucas P. Carvalho, Paulo Roberto Lima Machado, Gustavo Turecki, Acioly L.T. Lacerda, Lucas C. Quarantini,
Introduction: The use of ketamine as an option in the treatment of depressive disorder is growing rapidly, supported by numerous clinical trials attesting its efficacy and safety. Esketamine, the S (+) enantiomer of ketamine, is the most widely used form in the anesthetic environment in some countries, and new studies have shown that it may also be effective in depression and with better tolerability. However, no study so far has directly compared esketamine with racemic ketamine. Here we propose a ...
Tópico(s): Mental Health Research Topics
2018 - Wolters Kluwer | Medicine

... Bevilaqua, Iraja Ferreira Antunes, Janete Joanol Mastrantonio e Neander Teixeira Silveira – concentra-se sobre dados relativos a ...
Tópico(s): Banana Cultivation and Research
2013 - EMPRESA BRASILEIRA DE PESQUISA AGROPECUÁRIA | Cadernos de Ciência & Tecnologia